BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 18720096)

  • 41. [Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?].
    Kaden JJ; Haghi D; Vocke DC; Brueckmann M; Süselbeck T; Borggrefe M
    Med Klin (Munich); 2005 Jun; 100(6):334-9. PubMed ID: 15968485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons.
    di Sciascio G
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():41-3. PubMed ID: 18001321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycosaminoglycan synthesis and structure as targets for the prevention of calcific aortic valve disease.
    Grande-Allen KJ; Osman N; Ballinger ML; Dadlani H; Marasco S; Little PJ
    Cardiovasc Res; 2007 Oct; 76(1):19-28. PubMed ID: 17560967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.
    Mills EJ; Rachlis B; Wu P; Devereaux PJ; Arora P; Perri D
    J Am Coll Cardiol; 2008 Nov; 52(22):1769-81. PubMed ID: 19022156
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Calcific aortic stenosis: another face of atherosclerosis?
    Novaro GM; Griffin BP
    Cleve Clin J Med; 2003 May; 70(5):471-7. PubMed ID: 12779138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reassessment of statins to retard the progression of aortic stenosis.
    Rajamannan NM
    Curr Cardiol Rep; 2007 Apr; 9(2):99-104. PubMed ID: 17430676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of cardiovascular disease in chronic kidney disease patients.
    Wanner C
    Semin Nephrol; 2009 Jan; 29(1):24-9. PubMed ID: 19121471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Accelerated atherosclerotic calcification and Monckeberg's sclerosis: a continuum of advanced vascular pathology in chronic kidney disease.
    McCullough PA; Agrawal V; Danielewicz E; Abela GS
    Clin J Am Soc Nephrol; 2008 Nov; 3(6):1585-98. PubMed ID: 18667741
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genomics: the next step to elucidate the etiology of calcific aortic valve stenosis.
    Bossé Y; Mathieu P; Pibarot P
    J Am Coll Cardiol; 2008 Apr; 51(14):1327-36. PubMed ID: 18387432
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is there a role of statins in the prevention of aortic biological prostheses degeneration.
    Antonini-Canterin F; Zuppiroli A; Baldessin F; Popescu BA; Nicolosi GL
    Cardiovasc Ultrasound; 2006 Jun; 4():26. PubMed ID: 16805917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum gamma-glutamyltransferase activity is increased in patients with calcific aortic valve stenosis.
    Bozbas H; Yildirir A; Demir O; Cakmak A; Karacaglar E; Yilmaz M; Eroglu S; Pirat B; Ozin B; Muderrisoglu H
    J Heart Valve Dis; 2008 Jul; 17(4):371-5. PubMed ID: 18751465
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [New insight into the treatment of aortic stenosis].
    Pibarot P; Dumesnil JG; Mathieu P
    Med Sci (Paris); 2007 Jan; 23(1):81-7. PubMed ID: 17212936
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The pathology of atherosclerosis: plaque development and plaque responses to medical treatment.
    Insull W
    Am J Med; 2009 Jan; 122(1 Suppl):S3-S14. PubMed ID: 19110086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. New insights into the pathogenesis and prognosis of aortic sclerosis.
    Rugină M; Jurcuţ R; Jurcuţ C; Sălăgeanu A; Apetrei E
    Rom J Intern Med; 2004; 42(3):635-45. PubMed ID: 16366136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms of aortic valve calcification.
    Mohler ER
    Am J Cardiol; 2004 Dec; 94(11):1396-402, A6. PubMed ID: 15566910
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is it time for medical therapy for aortic valve disease?
    Rajamannan NM
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):845-54. PubMed ID: 15500430
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aortic stenosis and statins: more evidence of "pleotropy"?
    Borer JS
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):476-7. PubMed ID: 15731486
    [No Abstract]   [Full Text] [Related]  

  • 59. Are angiotensin converting enzyme inhibitors beneficial in patients with aortic stenosis?
    Shavelle DM
    Heart; 2005 Oct; 91(10):1257-9. PubMed ID: 16162605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.
    Williams B; Lacy PS; Cruickshank JK; Collier D; Hughes AD; Stanton A; Thom S; Thurston H;
    Circulation; 2009 Jan; 119(1):53-61. PubMed ID: 19103995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.